SummerHaven Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,851
| Closed | -$269K | – | 274 |
|
|
2023
Q2 | $269K | Sell |
13,851
-4,327
| -24% | -$84.1K | 0.17% | 190 |
|
|
2023
Q1 | $516K | Buy |
18,178
+570
| +3% | +$16.2K | 0.3% | 184 |
|
|
2022
Q4 | $515K | Buy |
17,608
+300
| +2% | +$8.77K | 0.31% | 187 |
|
|
2022
Q3 | $457K | Sell |
17,308
-1,296
| -7% | -$34.2K | 0.32% | 198 |
|
|
2022
Q2 | $827K | Hold |
18,604
| – | – | 0.56% | 78 |
|
|
2022
Q1 | $921K | Buy |
18,604
+862
| +5% | +$42.7K | 0.52% | 86 |
|
|
2021
Q4 | $903K | Hold |
17,742
| – | – | 0.49% | 98 |
|
|
2021
Q3 | $990K | Buy |
+17,742
| New | +$990K | 0.58% | 23 |
|